Cravacin (Deucravacitinib) is a tyrosine kinase 2 (TYK2) inhibitor indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.
-
2 Articles
-
1 Photos
-
0 Vidéos
-
Habitant 191/1, Bir Uttam Mir Shawkat SarakTejgaon C/A,Dhaka-1208, Bangladesh
-
Male
-
Suivi par 0 membre
Mises à jour récentes
-
Cravacin (Deucravacitinib) 6mg: Generic TYK2 Inhibitor for PsoriasisThe landscape of plaque psoriasis treatment has witnessed a revolutionary shift with the introduction of TYK2 inhibitors. For millions of individuals living with moderate-to-severe plaque psoriasis, the daily struggle involves managing itchy, scaly, and often painful skin lesions. While topical creams and traditional systemic treatments have long been the standard, many patients seek a more...0 Commentaires 0 Parts 79 Vue 0 AperçuConnectez-vous pour aimer, partager et commenter!
-
0 Commentaires 0 Parts 71 Vue 0 Aperçu
Plus de lecture